ONCY News and Press, Oncolytics Biotech Inc. From 12/09/19

December 9, 2019 Palm Beach, FL –December 9, 2019 – One of the latest market reports in the published by Credence Research, Inc. shows that the Multiple Myeloma Treatment market, which was valued at USD $8,398.3 Mn in 2016, is expected to reach USD $21,221.8 Mn ...

Pre-clinical and clinical data demonstrate synergies between pelareorep and the proteasome inhibitor carfilzomib through inflammation, apoptosis and tumor responses Data provides scientific rationale supporting the ongoing phase 1b trial in multiple myeloma patients SAN DIEGO, CA an...

SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / December 6, 2019 / Oncolytics Biotech ® Inc. (NASDAQ:ONCY)(TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that it received written notice from Nasdaq stating that it's minimum ...

Pelareorep is the only oncolytic virus with meaningful clinical data demonstrating intravenous delivery and replication in tumor tissue SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / December 3, 2019 / Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelar...

The biotech sector continues to grow as valuations are sky high, based on recent M&A’s within the industry. 2019 started off with a boom with the announcement of two multi-billion-dollar deals valued at a total $82 billion, one of them being among the top 10 highest valuations of a...

These 5 Penny Stocks Are Up Big But Are They Still A Buy? Most of the big markets like the S&P 500, Dow, and Nasdaq were down on November 21st. But this doesn’t mean you can’t make money in the stock market. When things get volatile, people start to look at some of the smalle...

The global biotech market will surpass $775 billion USD by 2024; according to a new research report by Global Market Insights, Inc. The industry is one of the most exciting sectors to follow ,acting as a strong engine of innovation, a source of highly skilled employment, and destination for i...

November 18, 2019 FN Media Group Presents USA News Group Market Commentary Los Angeles, CA – November 18, 2019 –  – USA News Group – A stunning revelation came back in April, when an Oxford published study pointed to only 3% of the cancer drug...

Oncolytics Biotech Inc. (ONCY) Q3 2019 Earnings Conference Call November 00, 2019 05:00 PM ET Company Participants Michael Moore - VP of IR & Corporate Communications Dr. Matt Coffey - President, CEO Kirk Look - CFO Andrew de Guttadauro - Global Head of Business Development...

Oncolytics Biotech (NASDAQ: ONCY ): Q3 net loss of $3.5M. Shares  +4% Press Release More news on: Oncolytics Biotech Inc., Earnings news and commentary, Healthcare stocks news, ,